BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu Q, Lu Z, Li H, Lu J, Guo L, Ge Q. Next-generation sequencing of microRNAs for breast cancer detection. J Biomed Biotechnol 2011;2011:597145. [PMID: 21716661 DOI: 10.1155/2011/597145] [Cited by in Crossref: 56] [Cited by in F6Publishing: 76] [Article Influence: 5.1] [Reference Citation Analysis]
Number Citing Articles
1 Mosapour A, Karami Tehrani FS, Atri M. Differential expression of miR-1297, miR-3191-5p, miR-4435, and miR-4465 in malignant and benign breast tumors. Iran J Basic Med Sci 2020;23:1045-52. [PMID: 32952951 DOI: 10.22038/ijbms.2020.44581.10421] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Galvão-Lima LJ, Morais AHF, Valentim RAM, Barreto EJSS. miRNAs as biomarkers for early cancer detection and their application in the development of new diagnostic tools. Biomed Eng Online 2021;20:21. [PMID: 33593374 DOI: 10.1186/s12938-021-00857-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Walter ND, Bemis L, Edwards M, Ovrutsky AR, Chan ED. Need for rigor in design, reporting, and interpretation of transcriptomic biomarker studies. J Clin Microbiol 2012;50:4190-1; discussion 4192-3. [PMID: 23162111 DOI: 10.1128/JCM.06775-11] [Reference Citation Analysis]
4 Wang J, Zhang KY, Liu SM, Sen S. Tumor-associated circulating microRNAs as biomarkers of cancer. Molecules. 2014;19:1912-1938. [PMID: 24518808 DOI: 10.3390/molecules19021912] [Cited by in Crossref: 104] [Cited by in F6Publishing: 104] [Article Influence: 13.0] [Reference Citation Analysis]
5 Seven M, Karatas OF, Duz MB, Ozen M. The role of miRNAs in cancer: from pathogenesis to therapeutic implications. Future Oncology 2014;10:1027-48. [DOI: 10.2217/fon.13.259] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 4.9] [Reference Citation Analysis]
6 Chong ZX, Yeap SK, Ho WY. Roles of circulating microRNA(s) in human breast cancer. Archives of Biochemistry and Biophysics 2020;695:108583. [DOI: 10.1016/j.abb.2020.108583] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Cui S, Cao Z, Guo W, Yu H, Huang R, Wu Y, Zhou Y. [Plasma miRNA-23a and miRNA-451 as candidate biomarkers for early diagnosis of nonsmall cell lung cancer: a case-control study]. Nan Fang Yi Ke Da Xue Xue Bao 2019;39:705-11. [PMID: 31270050 DOI: 10.12122/j.issn.1673-4254.2019.06.12] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Kinget L, Roussel E, Lambrechts D, Boeckx B, Vanginderhuysen L, Albersen M, Rodríguez-Antona C, Graña-Castro O, Inglada-Pérez L, Verbiest A, Zucman-Rossi J, Couchy G, Caruso S, Laenen A, Baldewijns M, Beuselinck B. MicroRNAs Possibly Involved in the Development of Bone Metastasis in Clear-Cell Renal Cell Carcinoma. Cancers (Basel) 2021;13:1554. [PMID: 33800656 DOI: 10.3390/cancers13071554] [Reference Citation Analysis]
9 Christodoulatos GS, Dalamaga M. Micro-RNAs as clinical biomarkers and therapeutic targets in breast cancer: Quo vadis? World J Clin Oncol 2014; 5(2): 71-81 [PMID: 24829853 DOI: 10.5306/wjco.v5.i2.71] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 35] [Article Influence: 4.6] [Reference Citation Analysis]
10 O'Brien KP, Ramphul E, Howard L, Gallagher WM, Malone C, Kerin MJ, Dwyer RM. Circulating MicroRNAs in Cancer. Methods Mol Biol 2017;1509:123-39. [PMID: 27826923 DOI: 10.1007/978-1-4939-6524-3_12] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
11 Shen J, Stass SA, Jiang F. MicroRNAs as potential biomarkers in human solid tumors. Cancer Lett. 2013;329:125-136. [PMID: 23196059 DOI: 10.1016/j.canlet.2012.11.001] [Cited by in Crossref: 153] [Cited by in F6Publishing: 153] [Article Influence: 15.3] [Reference Citation Analysis]
12 Nassar FJ, Nasr R, Talhouk R. MicroRNAs as biomarkers for early breast cancer diagnosis, prognosis and therapy prediction. Pharmacol Ther 2017;172:34-49. [PMID: 27916656 DOI: 10.1016/j.pharmthera.2016.11.012] [Cited by in Crossref: 103] [Cited by in F6Publishing: 109] [Article Influence: 17.2] [Reference Citation Analysis]
13 Koller K, Das S, Leuschner I, Korbelius M, Hoefler G, Guertl B. Identification of the transcription factor HOXB4 as a novel target of miR-23a. Genes Chromosomes Cancer 2013;52:709-15. [PMID: 23630040 DOI: 10.1002/gcc.22066] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
14 Bookland M, Tang-Schomer M, Gillan E, Kolmakova A. Circulating serum oncologic miRNA in pediatric juvenile pilocytic astrocytoma patients predicts mural nodule volume. Acta Neurochir (Wien) 2018;160:1571-81. [PMID: 29911246 DOI: 10.1007/s00701-018-3589-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
15 Ravelli A, Reuben JM, Lanza F, Anfossi S, Cappelletti MR, Zanotti L, Gobbi A, Senti C, Brambilla P, Milani M, Spada D, Pedrazzoli P, Martino M, Bottini A, Generali D; Solid Tumor Working Party of European Blood and Marrow Transplantation Society (EBMT). Breast cancer circulating biomarkers: advantages, drawbacks, and new insights. Tumour Biol 2015;36:6653-65. [PMID: 26307395 DOI: 10.1007/s13277-015-3944-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
16 Afzal S, Hassan M, Ullah S, Abbas H, Tawakkal F, Khan MA. Breast Cancer; Discovery of Novel Diagnostic Biomarkers, Drug Resistance, and Therapeutic Implications. Front Mol Biosci 2022;9:783450. [DOI: 10.3389/fmolb.2022.783450] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Huang Y, Yang YB, Zhang XH, Yu XL, Wang ZB, Cheng XC. MicroRNA-21 gene and cancer. Med Oncol. 2013;30:376. [PMID: 23277281 DOI: 10.1007/s12032-012-0376-8] [Cited by in Crossref: 63] [Cited by in F6Publishing: 59] [Article Influence: 7.0] [Reference Citation Analysis]
18 Bottani M, Banfi G, Lombardi G. Circulating miRNAs as Diagnostic and Prognostic Biomarkers in Common Solid Tumors: Focus on Lung, Breast, Prostate Cancers, and Osteosarcoma. J Clin Med 2019;8:E1661. [PMID: 31614612 DOI: 10.3390/jcm8101661] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 10.7] [Reference Citation Analysis]
19 Kang K, Peng X, Luo J, Gou D. Identification of circulating miRNA biomarkers based on global quantitative real-time PCR profiling. J Anim Sci Biotechnol 2012;3:4. [PMID: 22958414 DOI: 10.1186/2049-1891-3-4] [Cited by in Crossref: 59] [Cited by in F6Publishing: 51] [Article Influence: 5.9] [Reference Citation Analysis]
20 Ottman R, Nguyen C, Lorch R, Chakrabarti R. MicroRNA expressions associated with progression of prostate cancer cells to antiandrogen therapy resistance. Mol Cancer 2014;13:1. [PMID: 24387052 DOI: 10.1186/1476-4598-13-1] [Cited by in Crossref: 72] [Cited by in F6Publishing: 37] [Article Influence: 9.0] [Reference Citation Analysis]
21 Leidner RS, Li L, Thompson CL. Dampening enthusiasm for circulating microRNA in breast cancer. PLoS One. 2013;8:e57841. [PMID: 23472110 DOI: 10.1371/journal.pone.0057841] [Cited by in Crossref: 83] [Cited by in F6Publishing: 88] [Article Influence: 9.2] [Reference Citation Analysis]
22 Ardila-molano J, Vizcaíno M, Serrano ML. Circulating microRNAs as potential cancer biomarkers. Revista Colombiana de Cancerología 2015;19:229-38. [DOI: 10.1016/j.rccan.2015.08.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
23 Kaur H, Mao S, Shah S, Gorski DH, Krawetz SA, Sloane BF, Mattingly RR. Next-generation sequencing: a powerful tool for the discovery of molecular markers in breast ductal carcinoma in situ. Expert Rev Mol Diagn 2013;13:151-65. [PMID: 23477556 DOI: 10.1586/erm.13.4] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
24 Rzeszutek I, Singh A. Small RNAs, Big Diseases. Int J Mol Sci 2020;21:E5699. [PMID: 32784829 DOI: 10.3390/ijms21165699] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
25 Kodahl AR, Lyng MB, Binder H, Cold S, Gravgaard K, Knoop AS, Ditzel HJ. Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study. Mol Oncol 2014;8:874-83. [PMID: 24694649 DOI: 10.1016/j.molonc.2014.03.002] [Cited by in Crossref: 110] [Cited by in F6Publishing: 102] [Article Influence: 13.8] [Reference Citation Analysis]
26 Zeng MS. Noncoding RNAs in Cancer Diagnosis. Adv Exp Med Biol 2016;927:391-427. [PMID: 27376744 DOI: 10.1007/978-981-10-1498-7_15] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
27 Otoukesh B, Abbasi M, Gorgani HO, Farahini H, Moghtadaei M, Boddouhi B, Kaghazian P, Hosseinzadeh S, Alaee A. MicroRNAs signatures, bioinformatics analysis of miRNAs, miRNA mimics and antagonists, and miRNA therapeutics in osteosarcoma. Cancer Cell Int 2020;20:254. [PMID: 32565738 DOI: 10.1186/s12935-020-01342-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
28 Díaz-López A, Moreno-Bueno G, Cano A. Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives. Cancer Manag Res 2014;6:205-16. [PMID: 24812525 DOI: 10.2147/CMAR.S38156] [Cited by in Crossref: 29] [Cited by in F6Publishing: 75] [Article Influence: 3.6] [Reference Citation Analysis]
29 Larrea E, Sole C, Manterola L, Goicoechea I, Armesto M, Arestin M, Caffarel MM, Araujo AM, Araiz M, Fernandez-Mercado M, Lawrie CH. New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies. Int J Mol Sci 2016;17:E627. [PMID: 27128908 DOI: 10.3390/ijms17050627] [Cited by in Crossref: 139] [Cited by in F6Publishing: 134] [Article Influence: 23.2] [Reference Citation Analysis]
30 Wu Q, Wang C, Lu Z, Guo L, Ge Q. Analysis of serum genome-wide microRNAs for breast cancer detection. Clin Chim Acta 2012;413:1058-65. [PMID: 22387599 DOI: 10.1016/j.cca.2012.02.016] [Cited by in Crossref: 91] [Cited by in F6Publishing: 82] [Article Influence: 9.1] [Reference Citation Analysis]
31 Ma R, Jiang T, Kang X. Circulating microRNAs in cancer: origin, function and application. J Exp Clin Cancer Res. 2012;31:38. [PMID: 22546315 DOI: 10.1186/1756-9966-31-38] [Cited by in Crossref: 126] [Cited by in F6Publishing: 118] [Article Influence: 12.6] [Reference Citation Analysis]
32 Kang H, Hata A. Quantitative Real-Time PCR Analysis of MicroRNAs and Their Precursors Regulated by TGF-β Signaling. Methods Mol Biol 2016;1344:313-23. [PMID: 26520134 DOI: 10.1007/978-1-4939-2966-5_20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
33 Behbahani GD, Ghahhari NM, Javidi MA, Molan AF, Feizi N, Babashah S. MicroRNA-Mediated Post-Transcriptional Regulation of Epithelial to Mesenchymal Transition in Cancer. Pathol Oncol Res 2017;23:1-12. [DOI: 10.1007/s12253-016-0101-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 4.5] [Reference Citation Analysis]
34 Mutz KO, Heilkenbrinker A, Lönne M, Walter JG, Stahl F. Transcriptome analysis using next-generation sequencing. Curr Opin Biotechnol. 2013;24:22-30. [PMID: 23020966 DOI: 10.1016/j.copbio.2012.09.004] [Cited by in Crossref: 281] [Cited by in F6Publishing: 221] [Article Influence: 28.1] [Reference Citation Analysis]
35 Klinge CM. Non-Coding RNAs in Breast Cancer: Intracellular and Intercellular Communication. Noncoding RNA. 2018;4. [PMID: 30545127 DOI: 10.3390/ncrna4040040] [Cited by in Crossref: 39] [Cited by in F6Publishing: 51] [Article Influence: 9.8] [Reference Citation Analysis]
36 Kodahl AR, Zeuthen P, Binder H, Knoop AS, Ditzel HJ. Alterations in circulating miRNA levels following early-stage estrogen receptor-positive breast cancer resection in post-menopausal women. PLoS One 2014;9:e101950. [PMID: 25004125 DOI: 10.1371/journal.pone.0101950] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
37 Wang N, Tan HY, Feng YG, Zhang C, Chen F, Feng Y. microRNA-23a in Human Cancer: Its Roles, Mechanisms and Therapeutic Relevance. Cancers (Basel) 2018;11:E7. [PMID: 30577536 DOI: 10.3390/cancers11010007] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 6.3] [Reference Citation Analysis]
38 Li ZH, Xiong QY, Xu L, Duan P, Yang QO, Zhou P, Tu JH. miR-29a regulated ER-positive breast cancer cell growth and invasion and is involved in the insulin signaling pathway. Oncotarget 2017;8:32566-75. [PMID: 28427228 DOI: 10.18632/oncotarget.15928] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
39 Zhang J, Zhao H, Gao Y, Zhang W. Secretory miRNAs as novel cancer biomarkers. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2012;1826:32-43. [DOI: 10.1016/j.bbcan.2012.03.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
40 Fujiwara T, Uotani K, Yoshida A, Morita T, Nezu Y, Kobayashi E, Yoshida A, Uehara T, Omori T, Sugiu K, Komatsubara T, Takeda K, Kunisada T, Kawamura M, Kawai A, Ochiya T, Ozaki T. Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma. Oncotarget 2017;8:33375-92. [PMID: 28380419 DOI: 10.18632/oncotarget.16498] [Cited by in Crossref: 44] [Cited by in F6Publishing: 49] [Article Influence: 11.0] [Reference Citation Analysis]
41 Petri BJ, Klinge CM. Regulation of breast cancer metastasis signaling by miRNAs. Cancer Metastasis Rev 2020;39:837-86. [PMID: 32577859 DOI: 10.1007/s10555-020-09905-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]
42 Girotra S, Yeghiazaryan K, Golubnitschaja O. Potential biomarker panels in overall breast cancer management: advancements by multilevel diagnostics. Per Med 2016;13:469-84. [PMID: 29767597 DOI: 10.2217/pme-2016-0020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
43 Ohtsuka M, Iwamoto K, Naito A, Imasato M, Hyuga S, Nakahara Y, Mikamori M, Furukawa K, Moon J, Asaoka T, Kishi K, Shamma A, Akamatsu H, Mizushima T, Yamamoto H. Circulating MicroRNAs in Gastrointestinal Cancer. Cancers (Basel) 2021;13:3348. [PMID: 34283058 DOI: 10.3390/cancers13133348] [Reference Citation Analysis]
44 Mathe A, Scott RJ, Avery-Kiejda KA. MiRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer. Int J Mol Sci 2015;16:28347-76. [PMID: 26633365 DOI: 10.3390/ijms161226090] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 5.4] [Reference Citation Analysis]
45 Chakraborty C, Das S. Profiling cell-free and circulating miRNA: a clinical diagnostic tool for different cancers. Tumour Biol. 2016;37:5705-5714. [PMID: 26831657 DOI: 10.1007/s13277-016-4907-3] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 7.2] [Reference Citation Analysis]
46 Menéndez P, Villarejo P, Padilla D, Menéndez JM, Montes JA. Diagnostic and prognostic significance of serum microRNAs in colorectal cancer. J Surg Oncol. 2013;107:217-220. [PMID: 22903548 DOI: 10.1002/jso.23245] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
47 Cortez MA, Welsh JW, Calin GA. Circulating microRNAs as noninvasive biomarkers in breast cancer. Recent Results Cancer Res. 2012;195:151-161. [PMID: 22527502 DOI: 10.1007/978-3-642-28160-0_13] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 4.9] [Reference Citation Analysis]
48 Allam M, Spillings BL, Abdalla H, Mapiye D, Koekemoer LL, Christoffels A. Identification and characterization of microRNAs expressed in the African malaria vector Anopheles funestus life stages using high throughput sequencing. Malar J 2016;15:542. [PMID: 27825380 DOI: 10.1186/s12936-016-1591-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
49 Javidi MA, Ahmadi AH, Bakhshinejad B, Nouraee N, Babashah S, Sadeghizadeh M. Cell-free microRNAs as cancer biomarkers: the odyssey of miRNAs through body fluids. Med Oncol. 2014;31:295. [PMID: 25362261 DOI: 10.1007/s12032-014-0295-y] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
50 Swellam M, Ramadan A, El-Hussieny EA, Bakr NM, Hassan NM, Sobeih ME, EzzElArab LR. Clinical significance of blood-based miRNAs as diagnostic and prognostic nucleic acid markers in breast cancer: Comparative to conventional tumor markers. J Cell Biochem 2019;120:12321-30. [PMID: 30825229 DOI: 10.1002/jcb.28496] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
51 Kang K, Zhang X, Liu H, Wang Z, Zhong J, Huang Z, Peng X, Zeng Y, Wang Y, Yang Y, Luo J, Gou D. A novel real-time PCR assay of microRNAs using S-Poly(T), a specific oligo(dT) reverse transcription primer with excellent sensitivity and specificity. PLoS One 2012;7:e48536. [PMID: 23152780 DOI: 10.1371/journal.pone.0048536] [Cited by in Crossref: 72] [Cited by in F6Publishing: 68] [Article Influence: 7.2] [Reference Citation Analysis]
52 Gilam A, Shai A, Ashkenazi I, Sarid LA, Drobot A, Bickel A, Shomron N. MicroRNA regulation of progesterone receptor in breast cancer. Oncotarget 2017;8:25963-76. [PMID: 28404930 DOI: 10.18632/oncotarget.15657] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
53 Awasthi R, Rathbone MJ, Hansbro PM, Bebawy M, Dua K. Therapeutic prospects of microRNAs in cancer treatment through nanotechnology. Drug Deliv and Transl Res 2018;8:97-110. [DOI: 10.1007/s13346-017-0440-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
54 Swellam M, Mahmoud MS, Hashim M, Hassan NM, Sobeih ME, Nageeb AM. Clinical aspects of circulating miRNA‐335 in breast cancer patients: A prospective study. J Cell Biochem 2019;120:8975-82. [DOI: 10.1002/jcb.28168] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
55 Alyami NM. MicroRNAs Role in Breast Cancer: Theranostic Application in Saudi Arabia. Front Oncol 2021;11:717759. [PMID: 34760689 DOI: 10.3389/fonc.2021.717759] [Reference Citation Analysis]
56 Ma C, Zhang W, Wu Q, Liu Y, Wang C, Lao G, Yang L, Liu P. Identification of a microRNA signature associated with survivability in cervical squamous cell carcinoma. PLoS One 2018;13:e0193625. [PMID: 29513728 DOI: 10.1371/journal.pone.0193625] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
57 Ma Y, Wang X, Jin H. Methylated DNA and microRNA in body fluids as biomarkers for cancer detection. Int J Mol Sci. 2013;14:10307-10331. [PMID: 23681012 DOI: 10.3390/ijms140510307] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
58 Jaiswal R, Luk F, Gong J, Mathys JM, Grau GE, Bebawy M. Microparticle conferred microRNA profiles--implications in the transfer and dominance of cancer traits. Mol Cancer. 2012;11:37. [PMID: 22682234 DOI: 10.1186/1476-4598-11-37] [Cited by in Crossref: 77] [Cited by in F6Publishing: 78] [Article Influence: 7.7] [Reference Citation Analysis]
59 Goh JN, Loo SY, Datta A, Siveen KS, Yap WN, Cai W, Shin EM, Wang C, Kim JE, Chan M, Dharmarajan AM, Lee AS, Lobie PE, Yap CT, Kumar AP. microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer: microRNAs in breast cancer. Biol Rev 2016;91:409-28. [DOI: 10.1111/brv.12176] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 7.9] [Reference Citation Analysis]
60 Schmalfuss F, Kolominsky-Rabas PL. Personalized medicine in screening for malignant disease: a review of methods and applications. Biomark Insights 2013;8:9-14. [PMID: 23471146 DOI: 10.4137/BMI.S11153] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
61 Kinget L, Roussel E, Verbiest A, Albersen M, Rodríguez-Antona C, Graña-Castro O, Inglada-Pérez L, Zucman-Rossi J, Couchy G, Job S, de Reyniès A, Laenen A, Baldewijns M, Beuselinck B. MicroRNAs Targeting HIF-2α, VEGFR1 and/or VEGFR2 as Potential Predictive Biomarkers for VEGFR Tyrosine Kinase and HIF-2α Inhibitors in Metastatic Clear-Cell Renal Cell Carcinoma. Cancers (Basel) 2021;13:3099. [PMID: 34205829 DOI: 10.3390/cancers13123099] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Wu Q, Wang C, Guo L, Ge Q, Lu Z. Identification and characterization of novel microRNA candidates from deep sequencing. Clin Chim Acta 2013;415:239-44. [PMID: 23153516 DOI: 10.1016/j.cca.2012.11.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
63 Donadelli M, Dando I, Fiorini C, Palmieri M. Regulation of miR-23b expression and its dual role on ROS production and tumour development. Cancer Letters 2014;349:107-13. [DOI: 10.1016/j.canlet.2014.04.012] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
64 Ioannidis J, Donadeu FX. Changes in circulating microRNA levels can be identified as early as day 8 of pregnancy in cattle. PLoS One 2017;12:e0174892. [PMID: 28380001 DOI: 10.1371/journal.pone.0174892] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
65 Wang H, Zhang P, Chen W, Feng D, Jia Y, Xie L. Serum microRNA signatures identified by Solexa sequencing predict sepsis patients' mortality: a prospective observational study. PLoS One 2012;7:e38885. [PMID: 22719975 DOI: 10.1371/journal.pone.0038885] [Cited by in Crossref: 94] [Cited by in F6Publishing: 95] [Article Influence: 9.4] [Reference Citation Analysis]
66 Ivanov YD, Goldaeva KV, Malsagova KA, Pleshakova TO, Galiullin RA, Popov VP, Kushlinskii NE, Alferov AA, Enikeev DV, Potoldykova NV, Archakov AI. Nanoribbon Biosensor in the Detection of miRNAs Associated with Colorectal Cancer. Micromachines (Basel) 2021;12:1581. [PMID: 34945431 DOI: 10.3390/mi12121581] [Reference Citation Analysis]
67 Chen J, Yao D, Li Y, Chen H, He C, Ding N, Lu Y, Ou T, Zhao S, Li L, Long F. Serum microRNA expression levels can predict lymph node metastasis in patients with early-stage cervical squamous cell carcinoma. Int J Mol Med 2013;32:557-67. [PMID: 23799609 DOI: 10.3892/ijmm.2013.1424] [Cited by in Crossref: 93] [Cited by in F6Publishing: 86] [Article Influence: 10.3] [Reference Citation Analysis]
68 Bertoli G, Cava C, Castiglioni I. MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer. Theranostics 2015;5:1122-43. [PMID: 26199650 DOI: 10.7150/thno.11543] [Cited by in Crossref: 464] [Cited by in F6Publishing: 433] [Article Influence: 66.3] [Reference Citation Analysis]
69 Wang HJ, Zhou M, Jia L, Sun J, Shi HB, Liu SL, Wang ZZ. Identification of Aberrant Chromosomal Regions in Human Breast Cancer Using Gene Expression Data and Related Gene Information. Med Sci Monit 2015;21:2557-66. [PMID: 26319982 DOI: 10.12659/MSM.894887] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
70 Zidan HE, Abdul-Maksoud RS, Elsayed WSH, Desoky EAM. Diagnostic and prognostic value of serum miR-15a and miR-16-1 expression among egyptian patients with prostate cancer. IUBMB Life 2018;70:437-44. [PMID: 29522280 DOI: 10.1002/iub.1733] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
71 Hu R, Chen Y. Biocatalytic Amplification of UV Signal in Capillary Electrophoresis of MicroRNA. Int J Mol Sci 2019;21:E51. [PMID: 31861744 DOI: 10.3390/ijms21010051] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
72 Cava C, Bertoli G, Castiglioni I. Integrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potential. BMC Syst Biol 2015;9:62. [PMID: 26391647 DOI: 10.1186/s12918-015-0211-x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
73 Schrauder MG, Strick R, Schulz-Wendtland R, Strissel PL, Kahmann L, Loehberg CR, Lux MP, Jud SM, Hartmann A, Hein A, Bayer CM, Bani MR, Richter S, Adamietz BR, Wenkel E, Rauh C, Beckmann MW, Fasching PA. Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection. PLoS One 2012;7:e29770. [PMID: 22242178 DOI: 10.1371/journal.pone.0029770] [Cited by in Crossref: 173] [Cited by in F6Publishing: 160] [Article Influence: 17.3] [Reference Citation Analysis]
74 Beta M, Venkatesan N, Vasudevan M, Vetrivel U, Khetan V, Krishnakumar S. Identification and Insilico Analysis of Retinoblastoma Serum microRNA Profile and Gene Targets Towards Prediction of Novel Serum Biomarkers. Bioinform Biol Insights 2013;7:21-34. [PMID: 23400111 DOI: 10.4137/BBI.S10501] [Cited by in Crossref: 38] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]
75 Toraih EA, Mohammed EA, Farrag S, Ramsis N, Hosny S. Pilot Study of Serum MicroRNA-21 as a Diagnostic and Prognostic Biomarker in Egyptian Breast Cancer Patients. Mol Diagn Ther 2015;19:179-90. [PMID: 26063582 DOI: 10.1007/s40291-015-0143-6] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 7.3] [Reference Citation Analysis]
76 Chini VP. Micro-RNAs and next generation sequencing: new perspectives in heart failure. Clin Chim Acta 2015;443:114-9. [PMID: 25463748 DOI: 10.1016/j.cca.2014.11.020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
77 Guyon N, Garnier D, Briand J, Nadaradjane A, Bougras-Cartron G, Raimbourg J, Campone M, Heymann D, Vallette FM, Frenel JS, Cartron PF. Anti-PD1 therapy induces lymphocyte-derived exosomal miRNA-4315 release inhibiting Bim-mediated apoptosis of tumor cells. Cell Death Dis 2020;11:1048. [PMID: 33311449 DOI: 10.1038/s41419-020-03224-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
78 Gautam A, Kumar R, Dimitrov G, Hoke A, Hammamieh R, Jett M. Identification of extracellular miRNA in archived serum samples by next-generation sequencing from RNA extracted using multiple methods. Mol Biol Rep 2016;43:1165-78. [PMID: 27510798 DOI: 10.1007/s11033-016-4043-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
79 Chen G, Han N, Li G, Li X, Li G, Li Z, Li Q. Time course analysis based on gene expression profile and identification of target molecules for colorectal cancer. Cancer Cell Int 2016;16:22. [PMID: 27013928 DOI: 10.1186/s12935-016-0296-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]